DLL3 expression in large cell neuroendocrine carcinoma (LCNEC) and association with molecular subtypes and neuroendocrine profile

B. C. M. Hermans; J. L. Derks; E. Thunnissen; R. J. van Suylen; M. A. den Bakker; H. J. M. Groen; E. F. Smit; R. A. Damhuis; E. C. van den Broek; A. Ruland; E. J. M. Speel; A. M. C. Dingemans

doi:10.1016/j.lungcan.2019.10.010

DLL3 expression in large cell neuroendocrine carcinoma (LCNEC) and association with molecular subtypes and neuroendocrine profile

B. C. M. Hermans, J. L. Derks, E. Thunnissen, R. J. van Suylen, M. A. den Bakker, H. J. M. Groen, E. F. Smit, R. A. Damhuis, E. C. van den Broek, A. Ruland, E. J. M. Speel, A. M. C. Dingemans^*,

^*Corresponding author for this work

Research output: Contribution to journal › Article › Academic › peer-review

Original language	English
Pages (from-to)	102-108
Number of pages	7
Journal	Lung Cancer
Volume	138
DOIs	https://doi.org/10.1016/j.lungcan.2019.10.010
Publication status	Published - Dec 2019

Keywords

Large cell neuroendocrine carcinoma (LCNEC)
Lung cancer
DLL3
ASCL1
RB1
DELTA-LIKE 3
ANTIBODY-DRUG CONJUGATE
LUNG-CANCER
CHEMOTHERAPY
TESIRINE
THERAPY

Cite this

Hermans, B. C. M., Derks, J. L., Thunnissen, E., van Suylen, R. J., den Bakker, M. A., Groen, H. J. M., Smit, E. F., Damhuis, R. A., van den Broek, E. C., Ruland, A., Speel, E. J. M., Dingemans, A. M. C. (2019). DLL3 expression in large cell neuroendocrine carcinoma (LCNEC) and association with molecular subtypes and neuroendocrine profile. Lung Cancer, 138, 102-108. https://doi.org/10.1016/j.lungcan.2019.10.010

Hermans, B. C. M. ; Derks, J. L. ; Thunnissen, E. ; van Suylen, R. J. ; den Bakker, M. A. ; Groen, H. J. M. ; Smit, E. F. ; Damhuis, R. A. ; van den Broek, E. C. ; Ruland, A. ; Speel, E. J. M. ; Dingemans, A. M. C. / DLL3 expression in large cell neuroendocrine carcinoma (LCNEC) and association with molecular subtypes and neuroendocrine profile. In: Lung Cancer. 2019 ; Vol. 138. pp. 102-108.

@article{33dd20f337914beb9f03be409193b4fd,

title = "DLL3 expression in large cell neuroendocrine carcinoma (LCNEC) and association with molecular subtypes and neuroendocrine profile",

keywords = "Large cell neuroendocrine carcinoma (LCNEC), Lung cancer, DLL3, ASCL1, RB1, DELTA-LIKE 3, ANTIBODY-DRUG CONJUGATE, LUNG-CANCER, CHEMOTHERAPY, TESIRINE, THERAPY",

author = "Hermans, {B. C. M.} and Derks, {J. L.} and E. Thunnissen and {van Suylen}, {R. J.} and {den Bakker}, {M. A.} and Groen, {H. J. M.} and Smit, {E. F.} and Damhuis, {R. A.} and {van den Broek}, {E. C.} and A. Ruland and Speel, {E. J. M.} and Dingemans, {A. M. C.}",

year = "2019",

month = dec

doi = "10.1016/j.lungcan.2019.10.010",

language = "English",

volume = "138",

pages = "102--108",

journal = "Lung Cancer",

issn = "0169-5002",

publisher = "Elsevier Ireland Ltd",

}

Hermans, BCM , Derks, JL, Thunnissen, E, van Suylen, RJ, den Bakker, MA, Groen, HJM, Smit, EF, Damhuis, RA, van den Broek, EC, Ruland, A, Speel, EJM , Dingemans, AMC 2019, 'DLL3 expression in large cell neuroendocrine carcinoma (LCNEC) and association with molecular subtypes and neuroendocrine profile', Lung Cancer, vol. 138, pp. 102-108. https://doi.org/10.1016/j.lungcan.2019.10.010

DLL3 expression in large cell neuroendocrine carcinoma (LCNEC) and association with molecular subtypes and neuroendocrine profile. / Hermans, B. C. M.; Derks, J. L.; Thunnissen, E.; van Suylen, R. J.; den Bakker, M. A.; Groen, H. J. M.; Smit, E. F.; Damhuis, R. A.; van den Broek, E. C.; Ruland, A.; Speel, E. J. M.; Dingemans, A. M. C.

In: Lung Cancer, Vol. 138, 12.2019, p. 102-108.

Research output: Contribution to journal › Article › Academic › peer-review

TY - JOUR

T1 - DLL3 expression in large cell neuroendocrine carcinoma (LCNEC) and association with molecular subtypes and neuroendocrine profile

AU - Hermans, B. C. M.

AU - Derks, J. L.

AU - Thunnissen, E.

AU - van Suylen, R. J.

AU - den Bakker, M. A.

AU - Groen, H. J. M.

AU - Smit, E. F.

AU - Damhuis, R. A.

AU - van den Broek, E. C.

AU - Ruland, A.

AU - Speel, E. J. M.

AU - Dingemans, A. M. C.

PY - 2019/12

Y1 - 2019/12

KW - Large cell neuroendocrine carcinoma (LCNEC)

KW - Lung cancer

KW - DLL3

KW - ASCL1

KW - RB1

KW - DELTA-LIKE 3

KW - ANTIBODY-DRUG CONJUGATE

KW - LUNG-CANCER

KW - CHEMOTHERAPY

KW - TESIRINE

KW - THERAPY

U2 - 10.1016/j.lungcan.2019.10.010

DO - 10.1016/j.lungcan.2019.10.010

M3 - Article

VL - 138

SP - 102

EP - 108

JO - Lung Cancer

JF - Lung Cancer

SN - 0169-5002

ER -

Access to Document

10.1016/j.lungcan.2019.10.010